Pharma News

Keep updating your pharma knowledge
28 Jan 2019

Pfizer’s launches awareness and advocacy program on antibiotic resistance

This is a joint initiative between ICMR and Pfizer.


In February 2018, the Indian Council of Medical Research (ICMR) and Pfizer signed the first-ever public-private partnership on AMR in India. The aim of this partnership is to address the growing threat of antimicrobial resistance in India. The dedicated center that serves as a nodal point to launch pan-India interventions focusses on the four areas of Surveillance, Stewardship, Advocacy and Awareness:

  • Expanding ICMR’s Antimicrobial Stewardship Program across the country in a phased manner with focus on smaller in-patient centres (smaller hospitals and nursing homes).
  • Enhancing ICMR’s existing AMR Surveillance Program by training specialists to run an expanded  Surveillance Network that would cover both private and government hospitals to  collate, analyse and publish drug resistance data across all geographies in India.
  • Create awareness and advocacy program using media and non-media platforms to disseminate information on antibiotic resistance, promote rational use of antibiotics, encourage infection control techniques and organize conferences and awards to recognize best practices.
Pfizer’s AMR initiative is published on leading News Paper in India dated 28.01.2019


The Indian Council of Medical Research (ICMR), New Delhi, is the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world. ICMR’s research priorities align with the National health priorities

These  efforts  are  undertaken  with  a  view  to  reduce  the  total  burden  of  disease  and  to  promote health  and  well-being  of  the  population. ICMR promotes biomedical research in the country through intramural as well as extramural research.

ICMR launched the AMR initiative in 2013 and supports research leading to understanding trends and patterns of AMR in the country, understanding the mechanisms of resistance at molecular level, support antimicrobial stewardship efforts and the research efforts leading to development of new drugs and diagnostics. ICMR’s initiative spans medical colleges and hospitals, both from the private and government sector. ICMR is also partnering with CDC, USA, NIAID, USA, Research Council Norway and NIID Japan to support research in addressing different aspects of AMR.
Visit us at for more details.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!